Evaluation of the renal function in type 2 diabetes: Clearance calculation or cystatin C?;Évaluation de la fonction rénale chez le diabétique de type 2 : calcul des clairances ou cystatine C ?

Annales de Biologie Clinique

Volumn 70, Issue 3, 2012, Pages 287-294

  Dhia, Rym Ben ^a   Hellara, Ilhem ^a   Harzallah, Olfa ^a   Neffati, Fadoua ^a   Khochtali, Ines ^a   Mahjoub, Sylvia ^a   Najjar, Mohamed Fadhel ^a  

^a FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

Cockroft; Cystatin C; Kidney; MDRD; Type 2 diabetes

Indexed keywords

CREATININE; CYSTATIN C; URIC ACID;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; DIABETIC NEPHROPATHY; EVALUATION; FEMALE; HUMAN; KIDNEY FUNCTION TEST; MALE; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; MIDDLE AGED; MORPHOMETRICS; MOTOR ACTIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY; URINE;

ADULT; AGED; BODY WEIGHTS AND MEASURES; CASE-CONTROL STUDIES; CREATININE; CYSTATIN C; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; KIDNEY FUNCTION TESTS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MOTOR ACTIVITY; URIC ACID;

EID: 84861015418     PISSN: 00033898     EISSN: 19506112     Source Type: Journal    
DOI: 10.1684/abc.2012.0702     Document Type: Article

References (45)

1. Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985 ; 28 : 830-8. (Pubitemid 16156326)
2. Hoek FJ, Kemperman FA, Krediet RT. A comparison between cys-tatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 2003 ; 18:2024-31. (Pubitemid 37220307)
3. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, etal. National kidney foundation practice guidelines for chronic kid-ney disease : evaluation, classification, and stratification. Ann Intern Med 2003; 139 :137-47.
4. Rule AD, Bergstralh EJ, Slezak JM, Bergert J, Larson TS. Glomerular filtration rate estimated by cystatin C among different clinical presenta-tions. Kidney Int 2006; 69 :399-405. (Pubitemid 43323094)
5. Van den Berg E, Kloppenborg RP, Kessels RP, Kappelle LJ, Biessels GJ. Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity : a systematic comparison of their impact on cognition. Biochim Biophys Acta 2009; 1792:470-81.
6. Ooi EMM, Ng TWK, Chan DC, Watts GF. Plasma markers of choles-terol homeostasis in metabolic syndrome subjects with or without type-2 diabetes. Diab Res Clin Pract 2009 ; 85 :310-6.
7. Raman R, Gupta A, Pal SS, Ganesan S, Venkatesh K, Kulothungan V, et al. Prevalence of metabolic syndrome and it influence on micro-vascular complications in the Indian population with Type 2 Diabetes Mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 14). Diabetol Metab Syndr2010;2:67.
8. Yang YS, Peng CH, Lin CK, Wang CP, Huang CN. Use of serum cystatine C to detect early decline of glomerular filtration rate in type 2 diabetes. Intern Med 2007 ; 46: 801-6.
9. Finney H, Newman DJ, Price CP. Adults reference ranges for serum cystatine C, créatinine and predicted créatinine clearance. Ann Clin Bio-chem 2000; 37 :49-59. (Pubitemid 30064225)
10. Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 2009 ; 75 :652-60.
11. Groesbeck D, Köttgen A, Parekh R, Selvin E, Schwartz G, Coresch J, et al. Age, gender, and race effects on cystatin C levels in US adolescents. Clin JAm Soc Nephrol 2008 ; 3 :1777-85.
12. Knight EL, Verhave JC, Speiegelman D, Hillege HL, De Zeeuw D, Curhan GC, et al. Factors influencing serum cystatine C levels other than renal function and the impact on renal function measurement. Kidney Int 2004;65:1416-21. (Pubitemid 38406982)
13. Galteau MM, Guyon M, Gueguen R, Siest G. Determination of serum cystatin C : biological variation and references values. Clin Chem Lab Med 2001; 39 : 850-7. (Pubitemid 32899137)
14. Odden MC, Tager IB, Gansevoort RT, Bakker SJ, Katz R, Fried LF, et al. Age and cystatin C in healthy adults : a collaborative study. Nephrol Dial Transplant 2010 ; 25 :463-9.
15. Baxmann AC, Ahmed MS, Marques NC, Menon VB, Pereira AB, Kirsztajn GM, et al. Influence of muscle mass and physical activity on serum and urinary créatinine and serum cystatin C. Clin JAm Soc Nephrol 2008 ; 3 :348-54.
16. Evangelopoulos AA, Vallianou NG, Bountziouka VP, Giotopoulou AN, Bonou MS, Barbetseas J, etal. the impact of demographic charac-teristics and lifestyle in the distribution of cystatin C values in a healthy greek adult population. Cardiol Res Pract 2010; 2011:163281.
17. Naour N, Fellahi S, Renucci JF, Poitou C, Rouault C, Basdevant A, et al. Potential contribution of adipose tissue to elevated serum cystatin C in human obesity. Obesity (Silver Spring) 2009 ; 17 :2121-6.
18. Ichihara K, Saito K, Itoh Y. Sources of variation and reference inter-vals for serum cystatin C in a healthy Japanese adult population. Clin Chem Lab Med 2007 ; 45 :1232-6. (Pubitemid 47396261)
19. Sahakyan K, Klein BE, Lee KE, Tsai MY, Klein R. serum cystatin c and the incidence of hypertension in type 1 diabetes mellitus. Am J Hypertension 2011;24:59-63.
20. Koc M, Batur MK, Karaarslan O, Abali G. Clinical utility of serum cystatin C in predicting coronary artery disease. Cardiol J2010;17:374-80.
21. Koenig W, Twardella D, Brenner H, Rothenbacher D. Plasma concen-trations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events : more than simply a marker of glomerular filtation rate. Clin Chem 2005 ;51:321-7. (Pubitemid 40175801)
22. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Eng JMed 2005 ; 352:2049-60. (Pubitemid 40664306)
23. Wiesli P, Schwegler B, Spinas GA, Schmid C. Serum cystatin C is sensitive to small changes in thyroid function. Clin Chim Acta 2003 ;338:87-90. (Pubitemid 37456694)
24. Den Hollander JG, Wulkan RW, Mantel MJ, Berghout A. Corre-lation between severity of thyroid dysfunction and renal function. Clin Endocrinol (Oxf) 2005 ; 62:423-7.
25. De Boer IH, Astor BC, Kramer H, Palmas W, Seliger SL, Shlipak MG, et al . Lipoprotein abnormalities associated with mild impairment of kidney function in the multi-ethnic study of atherosclerosis. Clin JAm Soc Nephrol 2008 ; 3 :125-32.
26. El-Shafey EM, El-Nagar GF, Selim MF, El-Sorogy HA, Sabry AA. Is serum cystatin C an accurate endogenous marker of glomerular filtration rate for detection of early renal impairement in patients with type 2 diabetes mellitus ? Ren Fail 2009 ; 31:355-9.
27. Mojiminiyi OA, Abdella N, George S. Evaluation of serum cystatin C and chromogranin A as a markers of nephropathy in patients type 2 diabetes mellitus. Scand J Clin Lab Invest 2000; 60:483-9.
28. De Boer IH, Katz R, Cao JJ, Fried LF, Kestenbaum B, Mukamal K, et al. Cystatin C, albuminuria, and mortality among older adults with diabetes. Diabetes Care 2009 ; 32:1833-8.
29. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, etal. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease ? Hypertension 2003 ; 41:1183-90. (Pubitemid 36706063)
30. Muntner P, Vupputuri S, Coresh J, Uribarri j J, Fox CS. Metabolic abnormalities are present in adults with elevated serum cystatin C. Kidney Int2009 ;76:81-8.
31. Rosolowsky ET, Ficociello LH, Maselli NJ, Niewczas MA, Binns AL, Roshan B, et al . High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes. Clin JAm Soc Nephrol 2008 ; 3 :706-13.
32. Gerbes AL, Gülberg V, Bilzer M, Vogeser M. Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis oftheliver. Gut2002;50:106-10. (Pubitemid 34028312)
33. Li HX, Xu GB, Wang XJ, Zhang XC, Yang JM. Diagnostic accuracy of various glomerular filtration rates estimating equations in patients with chronic kidney disease and diabetes. Chin Med J (Engl) 2010;123:745-51.
34. Chudleigh RA, Ollerton LR, Dunseath G, Peter R, Harvey JN, Luzio S, etal. Use of cystatin C-based estimations of glomerular filtration rate in patients with type 2 diabetes. Diabetologia 2009 ; 52:1274-8.
35. Mussap M, Dalla M, Fioretto P, Saller A, Varagnolo M, Nosadini R, etal. Cystatin C is a more sensitive marker than créatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int 2002; 61:1453-61. (Pubitemid 34304506)
36. Bicik Z, Bahcebasi T, Kulaksizoglu S, Yavuz O. The efficacy of cystatin C assay in the prediction of glomerular filtration rate. Is it a more reliable marker for renal failure ? Clin Chem Lab Med 2005 ; 43 : 855-61. (Pubitemid 41461162)
37. Tan GD, Lewis AV, James TJ, Altmann P, Taylor RP, Levy JC. Clinical usefulness of cystatin C for the estimation of glomerular fil-tration rate in type 1 diabetes : reproductibility and accuracy compared with standard measures and iohexol clearance. Diabetes Care 2002; 25 : 2004-9. (Pubitemid 41071059)
38. Chantrel F, Agin A, Offner M, Koehl C, Moulin B, Hannedouche T. Comparison of cystatin C versus créatinine for detection of mild renal failure. Clin Nephrol 2000 ; 54 :374-81.
39. Donadio C, Lucchesi A. Serum cystatin as a marker of glomerular filtration rate. Am J Kidney Dis 2001;37:448-51. (Pubitemid 32116043)
40. Shimizu A, Horikoshi S, Rinnno H, Kobata M, Saito K, Tomino Y. Serum cystatin C may predict the early prognostic stages of patients with type 2 diabetic nephropathy. J Clin Lab Anal 2003 ; 17 :164-7. (Pubitemid 37128655)
41. Grubb A, Blirup-jensen S, Lindström V, Schmidt C, Althaus H, Zegers I ; IFCC (WG-SCC). First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clin Chem Lab Med 2010 ; 48 : 1619-21.
42. Dussol B. Méthodes d'exploration de la fonction rénale : intérêt et limites des formules permettant d'estimer la fonction rénale. Immunoanal Biol Spec 2011;26:6-12.
43. Panteghini M. Enzymatic assays for creatinine: time for action. Scand J Clin Lab Invest 2008 ; 68 : 84-8. (Pubitemid 351883664)
44. Delanaye P, Cavalier E, Maillard N, Krzesinski JM, Mariat C, Cristol JP, Piéroni L. La créatinine : d'hier à aujourd'hui. Ann Biol Clin 2010;68:531-43.
45. Bargnoux AS, Boutten A, Cambillau M, Carlier MC, Cavalier E, Cristol JP, etal. Recommandations pour le choix et l'harmonisation des techniques de dosage de la créatinine. Ann Biol Clin 2011;69:9-16.